CN107064482A - 一种单羟酚类代谢物人体尿液检测试剂 - Google Patents
一种单羟酚类代谢物人体尿液检测试剂 Download PDFInfo
- Publication number
- CN107064482A CN107064482A CN201710281321.7A CN201710281321A CN107064482A CN 107064482 A CN107064482 A CN 107064482A CN 201710281321 A CN201710281321 A CN 201710281321A CN 107064482 A CN107064482 A CN 107064482A
- Authority
- CN
- China
- Prior art keywords
- solution
- silicon oxide
- mesoporous silicon
- mercurous
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 78
- 238000001514 detection method Methods 0.000 title claims abstract description 77
- 210000002700 urine Anatomy 0.000 title claims abstract description 75
- 230000004060 metabolic process Effects 0.000 title claims abstract description 72
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 228
- 229910052814 silicon oxide Inorganic materials 0.000 claims abstract description 202
- BGARROUSYWXSED-UHFFFAOYSA-N dimercury(2+) Chemical compound [Hg+][Hg+] BGARROUSYWXSED-UHFFFAOYSA-N 0.000 claims abstract description 132
- ZELCNSAUMHNSSU-UHFFFAOYSA-N 3,5-diamino-2-[(4-sulfamoylphenyl)diazenyl]benzoic acid Chemical compound OC(=O)C1=CC(N)=CC(N)=C1N=NC1=CC=C(S(N)(=O)=O)C=C1 ZELCNSAUMHNSSU-UHFFFAOYSA-N 0.000 claims abstract description 99
- DRXYRSRECMWYAV-UHFFFAOYSA-N mercury(I) nitrate Inorganic materials [Hg+].[O-][N+]([O-])=O DRXYRSRECMWYAV-UHFFFAOYSA-N 0.000 claims abstract description 99
- CGFYHILWFSGVJS-UHFFFAOYSA-N silicic acid;trioxotungsten Chemical compound O[Si](O)(O)O.O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1.O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1.O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1.O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1 CGFYHILWFSGVJS-UHFFFAOYSA-N 0.000 claims abstract description 74
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims abstract description 61
- VZJXLUXABSAHBN-UHFFFAOYSA-N mercury;sulfuric acid Chemical compound [Hg].OS(O)(=O)=O VZJXLUXABSAHBN-UHFFFAOYSA-N 0.000 claims abstract description 53
- LGQLOGILCSXPEA-UHFFFAOYSA-L nickel sulfate Chemical compound [Ni+2].[O-]S([O-])(=O)=O LGQLOGILCSXPEA-UHFFFAOYSA-L 0.000 claims abstract description 53
- 229910000363 nickel(II) sulfate Inorganic materials 0.000 claims abstract description 53
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 239000000243 solution Substances 0.000 claims description 390
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 144
- 238000002360 preparation method Methods 0.000 claims description 93
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 78
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 53
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 43
- 238000001914 filtration Methods 0.000 claims description 43
- 229910017604 nitric acid Inorganic materials 0.000 claims description 43
- 239000007788 liquid Substances 0.000 claims description 40
- -1 ethane-epoxy propane-oxirane Chemical compound 0.000 claims description 34
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 33
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 32
- 239000007974 sodium acetate buffer Substances 0.000 claims description 32
- 238000003756 stirring Methods 0.000 claims description 32
- 239000004593 Epoxy Substances 0.000 claims description 31
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 30
- 229920000428 triblock copolymer Polymers 0.000 claims description 19
- 239000010703 silicon Substances 0.000 claims description 16
- 229910052710 silicon Inorganic materials 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 15
- 239000007787 solid Substances 0.000 claims description 15
- 239000004408 titanium dioxide Substances 0.000 claims description 15
- 239000000725 suspension Substances 0.000 claims description 14
- 239000000377 silicon dioxide Substances 0.000 claims description 13
- 238000002604 ultrasonography Methods 0.000 claims description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical class OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 3
- DOBUSJIVSSJEDA-UHFFFAOYSA-L 1,3-dioxa-2$l^{6}-thia-4-mercuracyclobutane 2,2-dioxide Chemical compound [Hg+2].[O-]S([O-])(=O)=O DOBUSJIVSSJEDA-UHFFFAOYSA-L 0.000 claims description 2
- 229940074994 mercuric sulfate Drugs 0.000 claims description 2
- 229910000372 mercury(II) sulfate Inorganic materials 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- CASPZMCSNJZQMV-UHFFFAOYSA-N ethane;2-methyloxirane Chemical compound CC.CC1CO1 CASPZMCSNJZQMV-UHFFFAOYSA-N 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 15
- 229920001577 copolymer Polymers 0.000 description 14
- 239000008351 acetate buffer Substances 0.000 description 13
- 229910021529 ammonia Inorganic materials 0.000 description 13
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 13
- 238000001816 cooling Methods 0.000 description 13
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 13
- 235000019441 ethanol Nutrition 0.000 description 12
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- BQPIGGFYSBELGY-UHFFFAOYSA-N mercury(2+) Chemical compound [Hg+2] BQPIGGFYSBELGY-UHFFFAOYSA-N 0.000 description 4
- 241000790917 Dioxys <bee> Species 0.000 description 3
- 229910003978 SiClx Inorganic materials 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000011056 performance test Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- DUUGKQCEGZLZNO-UHFFFAOYSA-N 5-hydroxyindoleacetic acid Chemical compound C1=C(O)C=C2C(CC(=O)O)=CNC2=C1 DUUGKQCEGZLZNO-UHFFFAOYSA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- RVWZUOPFHTYIEO-UHFFFAOYSA-N 5-hydroxyindoleacetic acid Natural products C1=C(O)C=C2C(C(=O)O)=CNC2=C1 RVWZUOPFHTYIEO-UHFFFAOYSA-N 0.000 description 1
- 239000003310 5-hydroxyindoleacetic acid Substances 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- AMDUMQZTBRMNMG-UHFFFAOYSA-N nickel nitric acid Chemical compound [Ni].O[N+]([O-])=O AMDUMQZTBRMNMG-UHFFFAOYSA-N 0.000 description 1
- 229940005654 nitrite ion Drugs 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- UHUUYVZLXJHWDV-UHFFFAOYSA-N trimethyl(methylsilyloxy)silane Chemical compound C[SiH2]O[Si](C)(C)C UHUUYVZLXJHWDV-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- CMPGARWFYBADJI-UHFFFAOYSA-L tungstic acid Chemical compound O[W](O)(=O)=O CMPGARWFYBADJI-UHFFFAOYSA-L 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Inorganic Chemistry (AREA)
- Biotechnology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710281321.7A CN107064482B (zh) | 2017-04-26 | 2017-04-26 | 一种单羟酚类代谢物人体尿液检测试剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710281321.7A CN107064482B (zh) | 2017-04-26 | 2017-04-26 | 一种单羟酚类代谢物人体尿液检测试剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107064482A true CN107064482A (zh) | 2017-08-18 |
CN107064482B CN107064482B (zh) | 2019-03-08 |
Family
ID=59604603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710281321.7A Expired - Fee Related CN107064482B (zh) | 2017-04-26 | 2017-04-26 | 一种单羟酚类代谢物人体尿液检测试剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107064482B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109115764A (zh) * | 2018-07-30 | 2019-01-01 | 深圳瑞达生物股份有限公司 | 环保型尿液羟苯衍生物检测试剂及其制备方法 |
CN110940663A (zh) * | 2019-12-26 | 2020-03-31 | 欧迪玛(湖北)生物科技有限公司 | 一种尿5-羟吲哚乙酸检测试剂及其制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101143724A (zh) * | 2006-09-11 | 2008-03-19 | 中国科学院过程工程研究所 | 十二烷基磺酸钠调控合成具有介孔孔道的二氧化硅空心球的方法 |
CN101857233A (zh) * | 2010-06-03 | 2010-10-13 | 中国药科大学 | 一种阴离子表面活性剂调控合成介孔二氧化硅微球的方法 |
CN102004103A (zh) * | 2010-10-13 | 2011-04-06 | 朱建华 | 用于检测人体尿液中酪氨酸类酚代谢物的试剂盒 |
CN103323452A (zh) * | 2013-06-21 | 2013-09-25 | 吉林生物研究院有限公司 | 对羟基苯丙氨酸尿液检测试剂及其制备方法 |
JP2014103924A (ja) * | 2012-11-28 | 2014-06-09 | National Institute Of Advanced Industrial & Technology | Dna合成酵素−シリカ系ナノ空孔材料複合体、その製造方法及び用途 |
CN105044100A (zh) * | 2015-07-28 | 2015-11-11 | 杭州欣叶生物科技有限公司 | 用于检测人体尿液中酪氨酸类酚代谢物的试剂盒 |
CN105203715A (zh) * | 2015-10-14 | 2015-12-30 | 中国科学院广州生物医药与健康研究院 | 一种利用介孔硅可控释放体系与血糖仪检测汞离子的方法 |
CN106190987A (zh) * | 2016-07-05 | 2016-12-07 | 浙江省疾病预防控制中心 | 一种基于氨基化硅胶浓缩检测水体中诺如病毒的方法 |
-
2017
- 2017-04-26 CN CN201710281321.7A patent/CN107064482B/zh not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101143724A (zh) * | 2006-09-11 | 2008-03-19 | 中国科学院过程工程研究所 | 十二烷基磺酸钠调控合成具有介孔孔道的二氧化硅空心球的方法 |
CN101857233A (zh) * | 2010-06-03 | 2010-10-13 | 中国药科大学 | 一种阴离子表面活性剂调控合成介孔二氧化硅微球的方法 |
CN102004103A (zh) * | 2010-10-13 | 2011-04-06 | 朱建华 | 用于检测人体尿液中酪氨酸类酚代谢物的试剂盒 |
JP2014103924A (ja) * | 2012-11-28 | 2014-06-09 | National Institute Of Advanced Industrial & Technology | Dna合成酵素−シリカ系ナノ空孔材料複合体、その製造方法及び用途 |
CN103323452A (zh) * | 2013-06-21 | 2013-09-25 | 吉林生物研究院有限公司 | 对羟基苯丙氨酸尿液检测试剂及其制备方法 |
CN105044100A (zh) * | 2015-07-28 | 2015-11-11 | 杭州欣叶生物科技有限公司 | 用于检测人体尿液中酪氨酸类酚代谢物的试剂盒 |
CN105203715A (zh) * | 2015-10-14 | 2015-12-30 | 中国科学院广州生物医药与健康研究院 | 一种利用介孔硅可控释放体系与血糖仪检测汞离子的方法 |
CN106190987A (zh) * | 2016-07-05 | 2016-12-07 | 浙江省疾病预防控制中心 | 一种基于氨基化硅胶浓缩检测水体中诺如病毒的方法 |
Non-Patent Citations (1)
Title |
---|
MISATO SAKAMOTO, ET AL.: "Visual Assay of Total Iron in Human Serum with Bathophenanthrolin Disulfonate-accommodated MCM-41.", 《ANALYTICAL SCIENCES》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109115764A (zh) * | 2018-07-30 | 2019-01-01 | 深圳瑞达生物股份有限公司 | 环保型尿液羟苯衍生物检测试剂及其制备方法 |
CN110940663A (zh) * | 2019-12-26 | 2020-03-31 | 欧迪玛(湖北)生物科技有限公司 | 一种尿5-羟吲哚乙酸检测试剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107064482B (zh) | 2019-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104535565B (zh) | 单羟酚类代谢物尿液检测试剂及其制备方法 | |
Takeuchi | Biology and treatment of cervical adenocarcinoma | |
CN103323452B (zh) | 对羟基苯丙氨酸尿液检测试剂的制备方法 | |
Demers et al. | Increasing incidence of cancer of the prostate: the experience of black and white men in the Detroit metropolitan area | |
CN104568923A (zh) | 电化学发光检测外周血循环肿瘤细胞抗原的方法及试剂盒 | |
WO2016066054A1 (zh) | 尿液中肿瘤标志物5-羟吲哚乙酸检测试剂及制备方法 | |
CN107064482B (zh) | 一种单羟酚类代谢物人体尿液检测试剂 | |
Kołaczyk et al. | Pulmonary benign metastasizing leiomyoma from the uterine leiomyoma: a case report | |
Naoe et al. | Brain metastasis from gastrointestinal stromal tumor: a case report and review of the literature | |
Tarallo et al. | Magnetic resonance imaging in locally advanced rectal cancer: quantitative evaluation of the complete response to neoadjuvant therapy | |
Saatli et al. | Synchronous tumors of the female genital tract: a 20-year experience in a single center | |
CN106796244A (zh) | 用以判断子宫内膜异位性卵巢囊肿致癌可能性之资料取得方法及其诊断装置 | |
CN107084977A (zh) | 尿液中酪氨酸酚类代谢物的检测试剂及其制品 | |
Lee et al. | Uterine angiomyolipoma with metastasis in a woman with tuberous sclerosis: a case report | |
Du et al. | Pure large cell neuroendocrine carcinoma originating from the endometrium: A case report | |
CN102749453A (zh) | 维甲酸诱导蛋白rai16用作肝细胞癌标志物的应用 | |
CN105353127A (zh) | 一种可以检测多种肿瘤的组合物及其应用 | |
CN102735831B (zh) | 截短型维甲酸诱导蛋白tRAI16用作肝细胞癌标志物的应用 | |
Al-Umairi et al. | Solid pseudopapillary tumor in a pregnant woman: imaging findings and literature review | |
CN104713874B (zh) | 乳腺癌尿液检测试剂和检测试剂盒及其制备和检测方法 | |
Tamaki et al. | Metachronous Sporadic Desmoid Tumors Arisen in the Stomach and the Cecum | |
Sun et al. | Insights of modern pathology reports originating from prostate biopsy and radical prostatectomy specimens | |
Achariyapota et al. | Prevalence and incidence of anemia in Thai patients with gynecologic cancer | |
CN110940663A (zh) | 一种尿5-羟吲哚乙酸检测试剂及其制备方法 | |
CN107121427A (zh) | 人体尿液中酪氨酸酚类代谢物的检测试剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190329 Address after: Room C-510-1, 198 Kaidi Road, Xiaoshan Economic and Technological Development Zone, Hangzhou City, Zhejiang Province Patentee after: Zhejiang Xinye Health Technology Co.,Ltd. Address before: Block C, Room 490, Unit 3, Building No. 1, 688 Qiushi Road, Jinshan Weizhen, Shanghai, 200540 Patentee before: SHANGHAI FEI JI BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190529 Address after: 311201 Room 420, Building 3, Xintang Kechuang Garden, 3089 Nanxiu Road, Xiaoshan District, Hangzhou City, Zhejiang Province Patentee after: Hangzhou Hongda Biotechnology Co.,Ltd. Address before: Room C-510-1, 198 Kaidi Road, Xiaoshan Economic and Technological Development Zone, Hangzhou City, Zhejiang Province Patentee before: Zhejiang Xinye Health Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210604 Address after: Room 902, 9th floor, West building, building 6, no.735 Jianghong Road, Changhe street, Binjiang District, Hangzhou City, Zhejiang Province 310000 Patentee after: Zhejiang DaoJia Medical Technology Co.,Ltd. Address before: 311201 Room 420, Building 3, Xintang Kechuang Garden, 3089 Nanxiu Road, Xiaoshan District, Hangzhou City, Zhejiang Province Patentee before: Hangzhou Hongda Biotechnology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190308 |